Teladoc Health welcomes Eric Evans to its board of directors
In a significant development, Teladoc Health, Inc. (NYSE:TDOC), a global leader in whole-person virtual care, appointed Eric Evans to the company's board of directors today. Mr. Evans, who is currently serving as the Chief Executive Officer and Director of Surgery Partners, Inc. (NASDAQ:NASDAQ:SGRY), will join the board's compensation committee. He steps into this role following the retirement of Senator William Frist, M.D., earlier this year.
David B. Snow Jr., non-executive Chairman of Teladoc Health's board, expressed his pleasure at welcoming Mr. Evans to the team. He emphasized that Eric's unique blend of talent, experience, and mindset aligns perfectly with Teladoc Health's current trajectory as they strive to enhance their services and offerings, invest in an innovation pipeline, and deliver transformative healthcare solutions globally.
Mr. Evans brings nearly two decades of experience in integrated healthcare to Teladoc Health. As the CEO of Surgery Partners, a leading operator of surgical facilities with more than 180 locations nationwide, he has significantly scaled the business since his tenure began in early 2019. Under his leadership, Surgery Partners added a net 29 new facilities to its portfolio and saw a revenue growth of over 50% and earnings of over 70%. This performance has driven approximately $3.5 billion of market capitalization growth.
Before joining Surgery Partners, Mr. Evans served as President of Hospital Operations at Tenet Healthcare (NYSE:THC) where he was responsible for 68 acute care hospitals, 161 hospital-affiliated facilities, and more than 2,200 employed providers.
Mr. Evans expressed his excitement about joining the Teladoc Health board and stated that he has admired Teladoc Health for years for its innovative approach towards healthcare delivery for employers, health plans, governments, and individuals. He looks forward to collaborating with his fellow board members and the management team led by Jason Gorevic.
This announcement comes on the heels of Teladoc Health's second quarter financial results reported in July 2023, which revealed a 10% increase in revenues to $652.4 million and an adjusted EBITDA of $72.2 million, surpassing expectations. In the same month, Teladoc Health also expanded its collaboration in artificial intelligence with Microsoft (NASDAQ:MSFT) to address the healthcare workforce crisis.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Related Articles
Teladoc Health welcomes Eric Evans to its board of directors
